Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity
- PMID: 20444988
- PMCID: PMC2883900
- DOI: 10.1093/cvr/cvq127
Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity
Comment on
-
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.Cardiovasc Res. 2010 Jul 1;87(1):30-9. doi: 10.1093/cvr/cvq041. Epub 2010 Feb 5. Cardiovasc Res. 2010. PMID: 20139114
Similar articles
-
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.Cardiovasc Res. 2010 Jul 1;87(1):30-9. doi: 10.1093/cvr/cvq041. Epub 2010 Feb 5. Cardiovasc Res. 2010. PMID: 20139114
-
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.Cardiovasc Drugs Ther. 2008 Aug;22(4):265-74. doi: 10.1007/s10557-008-6094-y. Epub 2008 Mar 11. Cardiovasc Drugs Ther. 2008. PMID: 18327705
-
Use of erythropoietin for cardiovascular protection.Cardiovasc Drugs Ther. 2008 Aug;22(4):253-5. doi: 10.1007/s10557-008-6111-1. Epub 2008 May 24. Cardiovasc Drugs Ther. 2008. PMID: 18500549 No abstract available.
-
Erythropoietin: ready for prime-time cardioprotection.Trends Pharmacol Sci. 2008 May;29(5):258-67. doi: 10.1016/j.tips.2008.02.002. Epub 2008 Mar 21. Trends Pharmacol Sci. 2008. PMID: 18359096 Review.
-
Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa.Pharmacotherapy. 2002 Sep;22(9 Pt 2):150S-159S. doi: 10.1592/phco.22.14.150s.33400. Pharmacotherapy. 2002. PMID: 12222585 Review.
References
-
- de Boer RA, Pinto YM, van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation. 2003;10:113–126. - PubMed
-
- Hudlica O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992;72:369–417. - PubMed
-
- Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol. 1998;30:2531–2540. doi:10.1006/jmcc.1998.0824. - DOI - PubMed
-
- Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, et al. Cardioprotective and anti-apoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121:1912–1925. doi:10.1161/CIRCULATIONAHA.109.905471. - DOI - PMC - PubMed
-
- van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19–28. doi:10.1016/S0735-1097(99)00499-4. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical